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An immunoprecipitation assay for measuring synthe-
sis of murine terminal deoxynucleotidyltransferase (EC 
2.7.7.31) has been developed using rabbit antiserum to 
calf terminal transferase. The antiserum precipitates a 
single Mr = 60,000 polypeptide (TdT-60) from all cell 
lines and tissues that contain enzymologically demon-
strable terminal transferase. This polypeptide is not 
precipitated from labeled extracts of cells that lack 
terminal transferase by enzymological criteria. TdT -60 
fractionates with terminal transferase during phospho-
cellulose chromatography and sediments with it in a 
sucrose gradient. TdT-60 is not detectably processed to 
lower molecular weight polypeptides, and terminal 
transferase activity sediments as a Mr = 60,000 activity; 
thus, we believe it to be the active form of terminal 
transferase. Using this assay we have demonstrated 
that terminal transferase is synthesized in both the 
murine thymus and the bone marrow at a rate propor-
tional to its biochemically measured steady state level. 
After cortisone treatment of mice, the Mr = 60,000 
polypeptide disappears from the thymus and then reap-
pears as the thymus begins to be repopulated. 
Terminal deoxynucleotidyltransferase (nucleoside triphos-
phate: DNA nucleotidylexotransferase; EC 2.7.7.31) is an un-
usual DNA polymerase that can catalyze the addition of 
deoxyribonucleotides onto the 3' -OH end of an oligodeoxy-
nucleotide primer in the absence of a directing template (1-
3). It is normally found only in immature thymic lymphocytes 
(4-9) and in bone marrow lymphocytes (6, 7, 10). Bone marrow 
terminal transferase 1 is restricted to larger, less dense ceUs 
(11, 12), at least some of which are committed to the T-
lymphocyte pathway and may be prothymocytes (13, 14). The 
enzyme is also found in circulating lymphocytes during par-
ticular leukemic disease states (6, 7, 9, 15-22) and in the 
spleens of athymic nu/nu mice (23, 24) . All of these observa-
tions have been made using standard biochemical assays and 
many of them have been confirmed by both radioimmunoas-
say (25) and immunofluorescent assays (23, 26-28) . 
• This work was supported by Grant CA-14051 from the National 
Cancer Institute and Contract NOl-CP-53562 from the Division of 
Cancer Cause and Prevention, National Cancer Institute. The costs 
of publication of this article were defrayed in part by the payment of 
page charges. This article must therefore be hereby marked "adver-
tisement" in accordance with 18 U.S.C. Section 1734 solely to indicate 
this fact . 
t Present address, Sloan Kettering Memorial Institute, New York, 
N. Y. 10021. 
§Helen Hay Whitney Foundation Postdoctoral Fellow. 
~ American Cancer Society Research Professor. 
'The abbreviations used are: terminal transferase, terminal deox-
ynucleotidyltransferase; TdT -60, M, = 60,000 protein immunoprecip-
itated with antiserum prepared against terminal transferase; PBS, 1% 
Triton X-100, 10 mM sodium PO, (pH 7.5), and 100 mM NaCI. 
The detection of terminal transferase in lymphoid cells of 
a particular tissue does not, however, constitute proof that 
ceUs of that tissue are synthesizing terminal transferase. For 
example, it has been suggested that terminal transferase found 
in normal bone marrow is due to migration of terminal trans-
ferase-containing ceUs from the thymus to the marrow (14) . A 
similar migration explanation has been advanced to explain 
the presence of terminal transferase in some abnormally in-
flamed tonsils (29) and in the spleens of athymic nu/nu mice 
(13, 24) . An assay for the actual metabolic synthesis of ter-
minal transferase would be valuable for answering such ques-
tions. Such an assay could also determine whether terminal 
transferase is synthesized as two distinct polypeptide chains, 
which then associate into the dimer form found for purified 
calf terminal transferase (25, 30, 31), or whether there is 
processing of a larger entity to yield functional terminal trans-
ferase, as suggested by Johnson and Morgan (32). 
We report here the development of an immunoprecipitation 
assay for the metabolic synthesis of murine terminal transfer-
ase using a rabbit anti-calf terminal transferase serum. With 
this assay we have demonstrated that murine terminal trans-
ferase is synthesized as a single polypeptide of M, = 60,000 
that is not processed to another detectable form. We also 
show that terminal transferase is synthesized in both murine 
thymus and bone marrow at rates proportional to its biochem-
ically measured steady state level. While this manuscript was 
in preparation, Bollum and Brown (33) reported that immu-
noprecipitation of human lymphoblastoid tumor cells with a 
rabbit anti-calf terminal transferase precipitated a major pro-
tein band of M, = 58,000. 
MATERIALS AND METHODS 
Preparation of Terminal Transferase-Three milligrams of ter-
minal transferase were purified from 30 kg of calf thymus in collabo-
ration with the Tufts New England Enzyme Center (Boston, MA). 
The initial steps in the purification duplicated the methods of Y oneda 
and Bollum (34) and Chang and Bollum (30) . Tissue was homogenized 
in NaCl/KPO, buffer, pH 7.2, and clarified by low speed centrifuga-
tion. The supernatant was acidified to pH 6.5 and then adsorbed to 
phosphoceUulose (Whatman). The enzyme was eluted from the resin 
by increasing the pH to 7.2 and the phosphate concentration to 250 
mM. The pooled peak then was passed through a Whatman DEll 
(DEAE-cellulose) column to remove nucleic acids. The resulting 
material was dialyzed and concentrated using an ultrafiltration ap-
paratus and then was adsorbed to a second phosphocellulose column. 
Enzyme was again batch-eluted with high phosphate and the pooled 
peak was collected as a 35 to 55% ammonium sulfate fraction. The 
enzyme then was resuspended and treated with cacodylic acid, pH 
4.5, to inactivate and remove other DNA polymerases. The superna-
tant, containing terminal transferase activity, was again concentrated 
with ammonium sulfate. This material was suspended in acid phos-
phate, dialyzed into 50 mM Tris -HCl (pH 7.7) , I mM EDTA, 1 mM 2-
mercaptoethanol, and adsorbed and eluted from phosphocellulose 
using a linear KCl gradient as previously described (15). The resulting 
peak fractions were pooled and fractionated on a Sephadex G-100 
(Pharmacia) column, using 12 mM phosphate buffer, pH 7.2, and 1 
mM dithiothreitol. The peak material, with a mean molecular weight 
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792 Biosynthesis of Terminal Transferase 
of approximately 35,000, then was adsorbed to an oligo(dT)-cellulose 
resin (T-2, Collaborative Research, Waltham, MA) , in a manner 
similar to that described by Okamura et al. (31) , except that the 
adsorption was done with 10 mM KH2PO .. / K2HPO, (pH 7.2), I mM 
dithiothreitol , 50 mM KCI. and 20% v/ v glycerol. T erminal transferase 
activity was e lu ted from this column using a linear salt gradient. This 
materia l was used as a source of antigen in most cases. In some cases, 
a more highly purified enzyme preparation was made from the 
oligo(dT)-purified materia l using hydroxylapatite chromatography 
(30). Sodium dodecyl sulfate-polyac rylamide gel electrophoresis of 
the various frac tions during purification showed that by Coomassie 
blue staining bands of M , = 28,000 and 8,000 became major compo-
nents only after the oligo(dT)-cellulose chromatography (Fig. 1) . 
These two bands have previously been shown to constitute purified 
calf terminal transferase (30) . The mate ria l purified through hydrox-
ylapatite was even purer than the oligo(dT)-purified fractions a l-
though the limited amount available did not a llow as much to be 
analyzed (Fig. I, Lane D) . 
Preparation of Antiserum-Antiserum to calf terminal transferase 
was prepared by injecting two rabbits with alum-adsorbed terminal 
t ransferase as described previously for immunization of mice (25) . 
Initial immunizations were done with oligo(dT) -purified enzyme (I 70 
l'g/ rabbit) and the first booster immunizations were done with hy-
droxylapatite-purified materia l (75 to I 00 Jlg of terminal transferase 
protein / rabbit). Successive booster immunizations were done with 
100 l'g of oligo(dT)-purified terminal transferase every 3 to 4 weeks. 
T he antisera used in our studies inhibited calf terminal transferase 
enzyme activity more than 70% at a dilution of 1:80 in an assay 
identical to that described in Kung et al. (25). Like the mouse sera 
used previously (25) , these rabbit sera did not inhibit normal murine 
DNA polymerases-a and -{1. 
Cell Lines-RL01I is a cloned subline derived from in vitro- pas-
saged HLO I, a radiat ion-induced BALB/c leukemia, derived by Dr. 
E. A. Boyse (28). 18-48 and 18-81 are clones derived from leukemic 
cell lines induced in vitro from BALB/c bone marrow cells with 
Abelson murine leukemia virus by Dr. N. Rosenberg (28, 35). CEL-42 
is a clone derived from an in vitro-passaged EL4 tumor donated to 
the MIT Cell Culture Center. Cells were isola ted from spleen, thymus, 
and bone marrow as previously described (1 3) except that a buffer 
developed by Dr. V. Sato (Harvard University) was used to prevent 
ce ll clumping (Eagle's minimal essent ial medium with Hank's salts 
and L-glu tamine, without sodium bicarbonate (Gibco 410-1200), sup-
plemented with I mM MgCb and I mM sodium phosphate and 
adjusted to pH 7.05). 
In cases where there were large numbers of dead cells (as in the 
cort isone experiments), viability was increased by suspending the 
cells in a 35% bovine serum albumin solu tion (Miles, Pathocyte 5) , 
and overlaying with a 10 or 15% bovine serum albumin solu t ion in a 
nitrocellulose centrifuge tube (Beckman). T his step gradient was then 
centrifuged to equilibrium at 15,000 to 16,000 rpm for 30 min in a 
swinging bucket rotor (SW 41 or S W 50. 1) at 4°C. Viable ce lls band 
at the density interface, whereas dead cells sediment to the bottom of 
the tube. Recovery is more than 80% and resulting viability greater 
than 95%. 
Biosynthetic Labeling and lmmunoprecipitation-ln most cases 
107 cells were washed with Du lbecco's modified Eagle's medium 
lacking serum and methionine and then suspended in the same 
medium in a 2-ml volume with 100 to 200 1-'Ci of ['"'Slmethionine 
(New England Nuclear Corp.) . Following the labeling period, the ce lls 
were harvested by low speed centrifugation and the supernatant was 
removed. Lysates were prepared for immunoprecipitation using the 
phosphate and detergent lysis buffer described in Witte and Baltimore 
(36) . This buffer contains 10 mM NaPO., (pH 7.5), 100 mM NaCI, I% 
T riton X-100, 0.5% deoxycholate, and 0.1% sodium dodecyl sulfate. In 
many cases, I mM phenylmethylsulfonyl fluoride (Sigma) and I mM 
EDTA were added to the lysis buffer to minimize proteolysis. 
The lysates were reacted with 5 111 of deaggregated antiserum for 
16 to 20 h at 4 °C and antigen . antibody complexes were precipitated 
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FIG . I (left) . The purification of calf terminal transferase. 
Samples at various stages in the purification of calf enzyme containing 
5 to 50 l'g of total protein were dissociated by boiling in gel sample 
buffer, then subjected to sodium dodecyl sulfate-polyacrylamide gel 
elec trophoresis analysis using the method of Laemmli (38) on a 5 to 
20% linear slab gel. The gel was stained with Coomassie brilliant blue, 
destained, and fixed with 10% acetic ac id , 10% methanol. A, pooled 
peak material from third phosphocellulose column (salt gradient 
elu tion) ; B , pooled peak materia l from G- 100 column; C, pooled peak 
mate rial from oligo(dT)-cellulose column; D, pooled peak material 
from hydroxylapatite chromatography. 
FIG. 2 (center). Immunoprecipitation and electrophoretic 
analysis of terminal transferase in a murine tumor cell line . 
HLO II tumor cells were metabolically labeled for I h with 50 JlCi/ml 
of ('~'Slmethionine, and cell extracts were immunoprecipitated with 
rabbit anti-calf terminal transferase serum or normal rabbit serum. 
Each channel represents labeled protein from 5 X IO'' cells. Samples 
were denatured in 1% sodium dodecyl sulfate. I% 2-mercaptoethanol 
and analyzed on a sodium dodecyl sulfate/ 10% acrylamide gel (38) 
and developed b:v fluorography (39) . A, sample treated and precipi-
tated with anti-terminal transferase in I% Triton X-100, 10 mM NaPO., 
A B c D E 
I 2 I 2 I 2 I 2 12 
-
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• - 60K 
(pH 7.5), and 100 mM NaCI (PBS) ; B , sample treated and precipitated 
with normal rabbit serum in 1% Triton X-100, 10 mM NaPO, (pH 
7.5) + 100 mM NaCI; C, sample treated and precipitated with ant i-
te rminal transferase in PBS/ 0.1 % sodium dodecyl sulfa te; D, sample 
trea ted and precipitated with normal rabbit serum in PBS + 0.1% 
sodium dodecyl sulfate; E , sample treated and precipitated with anti -
terminal transferase in PBS + 0.1 % sodium dodecyl sulfate + 0.5% 
deoxycholate; F, sample treated and precipi tated with normal rabbit 
serum in PBS + 0. 1% sodium dodecyl sulfate in 0.5% deoxycholate; G, 
sample treated and precipitated with anti-terminal transferase in PBS 
+ 0.1 % sodium dodecyl sulfate + 0.5% deoxycholate + I% Triton X-
100; H, sample treated and precipi tated with normal rabbit serum in 
PBS + 0.1% sodium dodecyl sulfate + 0.5% deoxycholate+ I% Triton 
X-100. 
FIG . 3 (right). Immunoprecipitation and electrophoretic 
analysis of terminal transferase in various m u rine tumor lines. 
Tumor cells metabolically labeled with [ '~'Slmethionine as described 
under "Materials and Methods" and cells were extracted and immu-
noprecipitated with 5 11l of anti-termina l transferase (Lane I) or 
normal rabbit serum (Lane 2). Samples were collected and analyzed 
as in Fig. 2. A , 18-81; B, 18-48; C, HLOII; D. CEL-42; F: , HRS-ST34. 
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Biosynthesis of Terminal Transferase 793 
using whole formalin-fixed Staphylococcus aureus according to the 
method of Kessler (37). Precipitates were washed with lysis buffer, 
resuspended in sample buffer (50 mM Tris-HCl (pH 6.8), 2.5% 2-
mercaptoethanol, 1% sodium dodecyl sulfate), and boiled for 2 min. 
Reduced samples were analyzed on sodium dodecyl sulfate-polyacryl-
amide gels of varying concentrations according to the method of 
Laemmli (38). Gels were stained with Coomassie brilliant blue R250 
(Eastman), fixed in 10% acetic acid, 10% methanol, and fluorographed 
according to Bonner and Laskey (39). 
Phosphocellulose Chromatography of Terminal Transferase and 
Enzyme Assays-Terminal transferase and DNA polymerase-a (EC 
2.7.7.7) were partially purified from crude cell extracts, as previously 
described (13), by adsorbing the enzymes to phosphocellulose resin 
and then eluting them with a linear KCI gradient. Enzyme assays 
used for terminal transferase and DNA polymerase-a were as previ-
ously described (13, 28). DNA polymerase-a was measured using a 
mixture of poly(dC) and poly(dl) as a template-primer combination 
(Miles) and measuring the incorporation of [3H]dGMP (New England 
Nuclear Corp.) into acid-precipitable material in the presence of Mg2+ 
ion (15). Under these conditions, murine terminal transferase will not 
catalyze the incorporation of label. Terminal transferase was assayed 
by the incorporation into acid-precipitable material of ['H]dGMP or 
[ 32P]dGMP in the presence of an oligo(dA)tz-ta (Collaborative Re-
search) primer and Mn2+ ion. 
Cortisone Treatment-Mice were injected with 2.5 mg of cortisone 
acetate (Upjohn Co.) as previously described (6). Cell suspensions 
were made from mice killed at the appropriate time after injection. 
RESULTS 
Anti-terminal Transferase Precipitates aM, = 60,000 Pro-
tein-To determine whether rabbit antiserum to calf terminal 
transferase could be used to analyze the metabolism of ter-
minal transferase in mice, we examined the ability of the 
serum to immunoprecipitate proteins from extracts of meta-
bolically labeled cells. In vitro-propagated RUll mouse tu-
mor cells, known to contain a high terminal transferase level 
by biochemical assay2 (28), were labeled with [358]methionine. 
Cell extracts were exposed to antiserum, the resulting antigen· 
antibody complexes were collected by binding to Staphylo-
coccus aureus, and the precipitates were analyzed by poly-
acrylamide gel electrophoresis in the presence of sodium do-
decyl sulfate as described elsewhere (36). A reproducible, 
major band of protein of M, = 60,000 (TdT -60) was observed 
when extracts were precipitated with anti-terminal transferase 
in the presence of three detergents (Fig. 2, Lane G). Normal 
rabbit serum did not immunoprecipitate any detectable TdT-
60 under these conditions (Fig. 2, Lane H). The three deter-
gents in the immunoprecipitation buffer were needed to main-
tain nonspecific precipitation at an acceptably low level; var-
ious other combinations of the detergents gave more bands 
that were precipitated by both immune and normal serum 
(Fig. 2, Lanes A to F). 
Because purified calf terminal transferase is known to have 
two subunits of M, = 27,000 and 8,000 (25, 30), the finding of 
a single polypeptide of M , = 60,0003 was surprising and we, 
therefore, designed a number of experiments to examine 
whether the band was truly terminal transferase. 
To ask whether the presence of enzymatically detected 
terminal transferase correlated with the presence of the TdT-
60 band, we studied a series of murine lymphoid tumor lines 
containing varying levels of terminal transferase. Lines RUll 
and CEL-42 contained easily detectable terminal transferase; 
the Abelson virus-induced line, 18-48, contained a low but 
2 A. Silverstone, L. Sun, 0. N. Witte, and D . Baltimore, unpublished 
data. 
3 The actual molecular weight of the TdT-60 polypeptide appears 
to be 55,000 to 60,000, depending on the electrophoresis system used 
and the markers chosen. Because determination of molecular weight 
by electrophoresis is not always accurate, we have designated the 
protein TdT-60 for convenience but its true molecular weight may be 
somewhat different and possibly nearer 55,000. 
measurable quantity of terminal transferase, and both the 
Abelson virus-induced line, 18-81, and the line derived from a 
spontaneous tumor, HRS-8T34, lacked detectable terminal 
transferase2 (28) . Occurrence of TdT-60 correlated with the 
enzymatically determined levels of terminal transferase (Fig. 
3): immune serum (Lane 1) but not normal rabbit serum 
(Lane 2) precipitated dark M , = 60,000 bands from RU11 
and CEL-42 (Fig. 3, C and D), a light band from 18-48 (Fig. 
3B), and no M, = 60,000 band from HR8-8T34 or 18-81 (Fig. 
3, E and A). With continuous passage, CEL-42lost enzymat-
ically detected terminal transferase as well as TdT -60; by 150 
generations both assays showed no detectable terminal trans-
ferase (data not shown) . By contrast, RUll cells maintained 
terminal transferase by both assays for more than 400 cell 
divisions. 
Relationship of TdT-60 and Terminal Transferase En-
zyme-To examine whether terminal transferase enzymatic 
activity and TdT-60 would co-purify, an extract of e58]me-
thionine-labeled RUll cells was chromatographed through 
phosphocellulose using a linear KCl gradient, and the fractions 
were assayed for enzyme activity. Although the 3~8-labeled 
proteins eluted broadly, terminal transferase eluted as a single 
peak (Fig. 4A) at a KCl concentration of 0.27 M KCl, which is 
in agreement with previous results (6, 23). lmmunoprecipita-
tion of the peak fraction of enzyme activity showed a strong 
M, = 60,000 band (Fig. 4C); fractions outside the enzyme peak 
had no specifically immunoprecipitable band (data not 
shown). 
The antiserum used for precipitation was made against 
terminal transferase purified by use of phosphocellulose chro-
matography and, thus, the finding of TdT-60 in the terminal 
transferase peak eluted from phosphocellulose does not prove 
whether TdT-60 is terminal transferase or a contaminant. To 
examine this question, we turned to a fractionation step not 
used in the terminal transferase purification, sucrose gradient 
sedimentation. The peak terminal transferase fractions eluted 
when the 358-labeled preparation was passed through phos-
phocellulose were pooled and sedimented through a sucrose 
gradient. The enzyme activity sedimented just behind a M, 
= 68,000 bovine serum albumin marker but well ahead of a 
M, = 43,000 ovalbumin marker (Fig. 4B). Thus, the enzyme 
behaved like a M, = 60,000 protein (and not like the M, = 
36,000 purified calf thymus terminal transferase). A variety of 
fractions were selected from the sucrose gradient and analyzed 
by immunoprecipitation for their content ofTdT-60 (Fig. 4C). 
Only the peak enzyme fractions had TdT -60. Thus, we can 
conclude that TdT-60 co-sediments with terminal transferase 
and that the size of terminal transferase by sedimentation is 
consistent with a M, = 60,000. 
Another test of the relationship of TdT -60 to terminal 
transferase enzyme was to compete its immunoprecipitation 
with purified calf terminal transferase. Enzyme purified by 
oligo(dT)-cellulose chromatography was mixed with extracts 
of terminal transferase-positive mouse cells and completely 
prevented precipitation of the M, = 60,000 band (data not 
shown). 
As a final test, the ability of the immunoprecipitation pro-
cedure to specifically remove terminal transferase from crude 
extracts of terminal transferase-positive mouse cells was ex-
amined. The extracts were exposed to anti-terminal transfer-
ase serum or normal rabbit serum, the antigen· antibody com-
plexes were removed by binding to S . aureus, and the remain-
ing proteins were chromatographed on phosphocellulose. En-
zyme assays showed that without added serum (Fig. 5A) or 
with normal rabbit serum (Fig. 5B) equal amounts of terminal 
transferase and normal cellular DNA polymerase-a were pres-
ent. The specific antiserum, however, removed terminal trans-
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FIG. 4. Co-purification of term inal transferase activity a nd 
T dT -60 by ion excha n ge ch romatography a nd glycerol grad i-
ent cen trifugation , A, thymocytes (3 x 10") from C57BL/ 6 mice 
were labeled with 2 mCi of ["''S]methionine (New England Nuclear, 
Boston, MAl for 1 h as described under "Materials and Methods." 
Cells were washed, pelleted, frozen, extracted, and prepared for chro-
matography as previously described (13). The extract was adsorbed 
to phosphocellulose in 50 mM KCl and then eluted with a gradient of 
100 mM to 1 M KCl. Fractions (0.4 ml) were analyzed for total 
['"'S]methionine counts/ 5 JLl (e--.) and for terminal transferase 
activity as picomoles/ h of each fraction employing [n P]dGTP ( 1000 
Ci/ mmol; Amersham, Chicago. IL) in reaction conditions previously 
described (1 3). B, material from the terminal transferase peak frac-
tion~ (hatched area J) was dia lyzed into 0.1 M K"HPO,.; KH"PO.I (pH 
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FIG. 5. Precip itation of murine ter m inal transferase activity 
by anti -calf term inal tran sfer a se a n tiseru m a nd S. aurew. 
Earl.v passage frozen CEL-42 cells, 4 X 10". were thawed and extracted 
with phenylmethylsulfonyl fluoride , Triton X-100. and KCl and di-
7.5), I mM 2-mercaptoethanol, and 5% sucrose and analyzed on a 
linear 5 to 20% sucrose gradient (SW 50.1 tube, Beckman Instruments, 
4°C, 42,000 rpm, 20 h) (4). Markers of M, = 68,000 (bovine serum 
albumin) and 43,000 (ovalbumin) were run on a parallel gradient. 
Fractions (0.13 ml) were analyzed for total ["''S]methionine counts/ 5 
Jll (0----0) and for terminal transferase activity as picomoles of 
[ " 1 P]dGTP incorporated/ h/ fraction using a cacodylate buffered assay 
(2, 13). C, equal volumes of material from each of the hatched areas 
(I to 5) were extracted, immunoprecipitated with 5 Jll of rabbit anti-
terminal transferase serum, and analyzed by sodium dodecyl sulfate-
polyacrylamide slab gel electrophoresis and fluorography as described 
under "Materials and Methods." Lane 6 represents a pool of Samples 
1 to 5 immunoprecipitated with normal rabbit serum. The flu orogram 
was exposed fo r 5 days. 
ferase from the extract while not reducing DNA polymerase-
a below the level left by normal rabbit serum (Fig. 5C). 
Therefore, by the correlation of the presence of terminal 
transferase enzyme and TdT-60 in a series of tumor cell lines, 
by sedimentation of terminal transferase activity and TdT-60, 
by the ability of terminal transferase to block precipitation of 
TdT-60, and by the ability of the anti-terminal transferase 
serum to precipitate terminal transferase activity selectively, 
we conclude that TdT-60 is mouse terminal transferase. Al-
though we have not had enough starting material to purify 
mouse terminal transferase to homogeneity, Ihle and Pazmino 
(Frederick Cancer Research Center, Maryland) found that 
terminal transferase partially purified from thymus tissue of 
2,000 mice had a molecular weight between 60,000 and 70,000 
by gel exclusion chromatography• 
Stability of the Metabolically Labeled Product-Because 
purified calf terminal transferase is composed of two chains 
(30) , we examined ifTdT-60 would be processed in cells. Early 
passage CEL-42 cells were labeled with ['"'C]methionine for 
15 min and then resuspended in unlabeled medium. T he 
pulse- labeled cells and cells chased for I or 3 h had approxi-
mately equal TdT-60 bands and there was no appearance of 
specifically precipitable bands other than TdT-60 (Fig. 6A) . 
With pulse- labeled RW ll cells, chases of 4, 10, or 24 h showed 
extensive loss of radioactivity from TdT-60 but no new labeled 
protein or cleavage fragments were observed. 
alyzed into low salt. A 100,000 x g supernatant was prepared and 
divided into 3- ml aliquots for treatment as below. A , no addition. 
These were a llowed to stand overnight. S. aureus was added in PBS 
to each and, after 60 min. antigen· antibody complexes were spun 
down. The supernatants were clarified and then adsorbed with phos-
phocellulose. Enzyme was eluted with a KCl salt gradient , and activity 
of DNA polymerase-" (0 ) and terminal transferase (e ) was measured 
(as referenced under " Materials and Methods") . 8, 330 Jll of normal 
rabbit serum was added. C. 330 Jll of anti-terminal transferase serum. 
·• J. N. lhle and N. H. Pazmino. personal communication. 
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FIG. 6 (left) . Pulse chase labeling of RWll and CEL-42 cells. 
CEL-42 or RWII cells were incubated at 37°C for 15 min in met-
Dulbecco's modified Eagle's medium + 50 !LCi/107 cells of ['"'S]me-
thionine, then pelleted and resuspended in complete medium with 
heat-inactivated fetal calf serum (20%). Samples were taken at the 
indicated times (h) and extracted for immune precipitation with anti-
terminal transferase (Lane 1) or normal rabbit serum (Lane 2). A, 
CEL-42 cells; B. RWII cells. 
FIG. 7 (center) . Tissue distribution ofTdT-60. Cell suspensions 
were prepared from (A) thymus and (B) bone marrow. Lymphoid 
cells, 2 x 107, from each tissue were incubated I h with 150 !LCi of 
['"'Slmethionine in medium lacking methionine as previously de-
scribed. Cells were lysed and processed for analysis in the presence of 
freshly added I mM phenylmethylsulfonyl fluoride. Immunoprecipi-
tation was carried out from 2 x 10'; acid-precipitable counts of material 
Tissue Distribution of TdT-60 Synthesis-Terminal trans-
ferase enzyme activity has been detected in thymus and bone 
marrow of normal mice (4, 6, 11) but not in spleen or other 
peripheral lymphoid tissue. These observations have been 
confirmed by radioimmunoassay (25) and immunofluores-
cence (23, 26, 28). To test whether terminal transferase is 
synthesized by thymus and bone marrow, cell suspensions 
from these organs were incubated in vitro with ['"'S]methio-
nine and extracts were immunoprecipitated as previously 
described. Both thymus and bone marrow showed a M , = 
60,000 protein precipitable with immune, but not with normal, 
serum (Fig. 7) . The band in bone marrow had approximately 
one-tenth the radioactivity as that from thymus, showing that 
the steady state levels of enzyme (6) correlate well with the 
synthetic rate. Also in agreement with measurement of steady 
state concentration was the fact that no synthesis of TdT-60 
was evident in spleen cell suspension (data not shown). 
It should be emphasized that the data in Fig. 7 was obtained 
by lysing cells in the presence of the protease inhibitor phen-
ylmethylsulfonyl fluoride. If it was omitted, no labeled TdT-
60 was recovered from bone marrow. This result is in agree-
ment with our earlier demonstration of proteolysis of terminal 
transferase in human bone marrow samples (7) . 
Effect of Cortisone on TdT-60 Synthesis-Cortisone treat-
ment of mice is known to kill most thymic lymphocytes over 
the course of 2 days, leaving a population of medullary thy-
mocytes depleted for terminal transferase (6). The thymus is 
later repopulated with lymphocytes that contain terminal 
transferase (40). To investigate whether changes in terminal 
transferase synthesis in the thymus parallel the changes in 
detected enzyme activity, thymocytes from control or corti-
sone-treated mice were removed at various times and labeled 
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from each tissue. Lane I , precipitation with normal rabbit serum: 
Lane 2, precipitation with anti-terminal transferase. 
FIG. 8 (right). Effect of cortisone upon terminal transferase 
synthesis in the thymus. Mice were inoculated with 2.5 mg of 
cortisone acetate and killed at various times after injection. Thymus 
cell suspensions were prepared and cells were metabolically labeled. 
Extracts and preparation of immunoprecipitates were all carried out 
in the presence of I mM phenylmethylsulfonyl fluoride . Dead cells 
were removed before labeling with a discontinuous 15:35% bovine 
serum albumin gradient as described under "Materials and Methods." 
All precipitations were carried out from !On acid precipitable counts 
of labeled material. Days I to 10, with anti-terminal transferase. 
Control: I, with anti-terminal transferase; N. with normal rabbit 
serum. Exposure was for 7 days. 
with C''S)methionine, and cell extracts were precipitated with 
anti-terminal transferase serum. At two days post-treatment, 
no M, = 60,000 band was evident but, by about Day 4, 
synthesis of terminal transferase was again demonstrable and 
increases to normal levels over 7 to 10 days (Fig. 8) . We have 
previously observed that terminal transferase activity in thy-
mus is separated into two forms by phosphocellulose chro-
matography, peak I and peak II (6, 9). After cortisone treat-
ment, peak II was reduced more than 50-fold on a per cell 
basis, but the level of peak I (originally representing 10% of 
the total terminal transferase activity) was reduced only 2-
fold . If this remaining activity represented synthesis at the 
preceding rate, we would have expected to find 5% as much 
synthesis as in the original thymus. Synthesis was detectable 
in the remaining thymocytes at about 5% of the initial ra te, 
suggesting that the peak I activity observed is in a cell type 
still synthesizing enzyme. 
DISCUSSION 
We have used a direct immunoprecipitation protocol (36) 
to study synthesis of murine terminal transferase in ['"'S]-
methionine-labeled cultured and primary cells. Because pure 
calf terminal transferase occurs as two polypeptides, we ex-
pected mouse terminal transferase to be a similar protein. 
When we found that aM,= 60,000 polypeptide (TdT-60) was 
the only one precipitated by immune, but not by normal, 
serum, we designed a variety of tests to show that TdT-60 
was truly terminal transferase and not an adventitious con-
taminant. 
Presence of TdT-60 a nd enzymatically defined terminal 
transferase correlated in a variety of cell lines and tissues. 
TdT-60 and terminal transferase both eluted from phospho-
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cellulose at about 0.27 M KCl and co-sedimented as M. = 
60,000 entities in sucrose gradients. Purified calf terminal 
transferase (the antigen used to raise the antiserum) blocked 
precipitation of TdT-60. (This circular experimental design 
would only be significant if no blocking was evident.) Finally, 
the antiserum specifically removed terminal transferase from 
a crude extract. 
If TdT-60 is terminal transferase, then why the difference 
between calf terminal transferase and mouse terminal trans-
ferase? We are not yet sure of the answer but Johnson and 
Morgan (32) may have provided the crucial clue by showing 
that a purification scheme for calf terminal transferase which 
avoided some of the harsher aspects of the classical method 
(34) resulted in aM.= 70,000 product. We have repeated their 
observation using another mild purification procedure.5 Pos-
sibly the two-chain structure of the pure calf terminal trans-
ferase is an artifact of proteolytic degradation. It is also 
possible that calf terminal transferase is processed intracellu-
larly to the two-chain form, but we could fmd no such proc-
essing of the murine enzyme. Murine TdT-60 had a half-life 
of less than 10 h in cultured thymoma cell lines (Fig. 6) but 
yielded no identifiable proteolytic fragments. In agreement 
with the recent report by Bollurn and Brown (33), Silverstone 
and de Sostoa6 have found that human terminal transferase 
is synthesized as a single polypeptide of about M. = 60,000 in 
both human tumor tissue and in normal bone marrow and 
thymus. 
The identification of terminal transferase by metabolic la-
beling and immunoprecipitation is a powerful tool with a 
sensitivity equal to enzymologic or immunofluorescent meth-
ods of detection. It gives information complementary to the 
other methods because it measures synthesis rate rather than 
steady state concentration. Like immunofluorescence, it mea-
sures enzyme physically but is less subjective than immuno-
fluorescence. 
The correlation we have found between terminal transferase 
enzyme and TdT-60 implies that none of the cells or tissues 
we have examined have detectable pools of inactive enzyme. 
Also, the detection of TdT-60 labeling in bone marrow at a 
10-fold lower rate than in thymus implies that the bone 
marrow terminal transferase (which occurs at a 10-fold lower 
concentration than in thymus) can be synthesized in marrow 
cells and does not come from cells that migrate with their 
enzyme to the marrow as suggested by Pazmino et al. (14). 
One fmal use of this technique has been to confmn earlier 
reports (28) that lymphoid cells transformed by Abelson mu-
rine leukemia virus contain terminal transferase. These cells 
display some B-lymphocyte characteristics (35) and, thus, 
provide evidence that terminal transferase may occur in both 
T-lymphocyte precursors and B-lyrnphocyte precursors as 
previously suggested (28). 
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